A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment.
What if one infusion could keep cholesterol down for a year? An experimental gene-editing treatment called CTX310 has shown early promise in people whose cholesterol and other blood fats remain high despite medication.
In a small Cleveland Clinic trial, patients who received the highest dose still had roughly half their original level of LDL, or “bad,” cholesterol a year later. The treatment works by switching off a gene in the liver.
That gene, called ANGPTL3, helps regulate blood fats. Switching it off can lower both LDL cholesterol and triglycerides, which are linked to heart disease. CTX310 delivers CRISPR-Cas9 editing machinery to the liver to make that change. CRISPR-Cas9 is a technology that allows researchers to modify specific regions of DNA.
Cholesterol reductions last a full year
The Phase 1 study was the first to test CTX310 in humans and included 15 patients with medication-resistant lipid disorders. Participants received a single infusion at doses ranging from 0.1 to 0.8 milligrams per kilogram of body weight, following pretreatment with corticosteroids and antihistamines. Researchers monitored safety and measured ANGPTL3, LDL cholesterol, and triglyceride levels.
Earlier findings had shown reductions in LDL cholesterol and triglycerides after two months. The new results examined whether those effects would last for 12 months. Reductions persisted across all doses through the year of follow-up. At the highest dose, LDL cholesterol was 52.5% below its pretreatment level, and triglycerides were 47.8% lower.
“Building upon the initial data presented in November 2025, the durability of the lipid-lowering effect was impressive,” said Dr. Luke Laffin, a Cleveland Clinic cardiologist and the study’s first author.
Tracking safety over the long term
No serious adverse events related to the therapy occurred during the one-year follow-up. The findings provide an early assessment of the treatment in a small group, with larger studies needed to investigate it further.
“It is encouraging that there were no serious safety events related to CTX310 in the trial and in the year following treatment. We look forward to continuing to investigate this therapy in a larger number of patients,” Laffin said.
Participants will undergo additional long-term safety follow-up planned for the next 15 years, as the FDA recommends for all gene-editing therapies.
Reference: “Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310” by Luke J. Laffin, Stephen J. Nicholls, Russell S. Scott, Peter M. Clifton, Renate Koops, Ashish Sarraju, Shweta Singh, Qiuqing Wang, Kathy Wolski, Huansheng Xu, Jen Nielsen, Naimish Patel, Jason M. Duran and Steven E. Nissen, 27 August 2026, New England Journal of Medicine.
DOI: 10.1056/NEJMc2609825
Meeting: 2026 European Society of Cardiology
The study was funded by CRISPR Therapeutics AG; Zug, Switzerland. Dr. Laffin’s institution has received research funding from Crispr Therapeutics.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Researcher at Russian plague laboratory dies of ‘unknown’ infection
Russian authorities have imposed "anti-epidemic measures" after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. The researcher, a 28-year-old female [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
A Surprising Brain Signal Could Explain Why Eating Less Protein Extends Lifespan
A new paper suggests that limiting protein intake triggers a coordinated response throughout the body that may help explain how protein restriction affects healthy aging. Animals respond to protein restriction, or reduced protein in [...]
Back and shoulder surgery is often worse than useless
Millions of operations should be scrapped SIX IN TEN Britons have surgery at some point. So do lots of Americans, at a cost of perhaps $500bn a year, a third of all spending on [...]
Cocaine plays with mind, hijacks brain circuit, drives increasingly rigid and repetitive behavior
Researchers have found that cocaine hijacks brain circuit, which to drive increasingly rigid and repetitive behavior. The brain circuit that normally participates in selecting natural mouth and face movements, but which becomes disproportionately engaged [...]
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
The brain cancer glioblastoma is one of the most aggressive and treatment-resistant cancers known to medicine, carrying a median survival of just 12-15 months, even with the best available care. Now, researchers at the [...]
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol [...]
Too Much RNA Can Drain a Cell’s Energy, Scientists Discover
A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences [...]
West African scientists warn of weakening health systems and urge stronger outbreak detection
LOME, Togo (AP) — West African laboratory scientists called on governments Friday to strengthen capacity to detect disease outbreaks to avoid another major outbreak, saying health systems across the region are becoming weaker. Participants [...]
A Little-Known Protein Could Point to a New Way To Treat Alzheimer’s
A study suggests that increasing SORLA protein levels could help treat Alzheimer’s disease and other disorders involving tau protein. Increasing SORLA, a protein with a protective role in the brain, helped mice withstand damage [...]
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
Two Hidden Forces Help Build the Human Brain Before Birth
Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known [...]
Researchers Uncover a Hidden Trigger Behind Chronic Inflammation
The findings offer new insights that could help guide the development of future therapies. A protein called human resistin may help flip on one of the immune system’s most powerful inflammatory switches. Researchers at [...]
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
